Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models
Irofulven, a novel chemotherapeutic agent with a broad spectrum of activity, is effective against preclinical models of pediatric tumors. The cytotoxic activity of irofulven is augmented when combined with age...
-
Article
Pharmacokinetics of paclitaxel in an anephric patient
Purpose: To assess the pharmacokinetics of paclitaxel for recurrent Wilms' tumor in an anephric pediatric patient receiving hemodialysis. Methods: Paclitaxel was administered at a dose of 250 mg/m2 and 350 mg/m2